Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. From Wikipedia
Data from 170,000 U.S. adults indicate that GLP-1 RA prescriptions reduce colon and rectal cancer risks by up to 28%
